• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 27
  • 19
  • 17
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • Tagged with
  • 70
  • 70
  • 70
  • 39
  • 32
  • 30
  • 28
  • 20
  • 20
  • 18
  • 17
  • 16
  • 15
  • 15
  • 15
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
21

Využití antimonových filmových elektrod pro stanovení pesticidu trifluralin / Application of Antimony Film Electrodes for Determination of Pesticide Trifluralin

Gajdár, Július January 2015 (has links)
Antimony film electrode was studied for the use in a voltammetric analysis of organic compounds. The substance chosen as an analyte was trifluralin, which is used as a pesticide. The comparison of different substrate electrodes was carried out between five electrodes, which were gold, silver, copper, polished amalgam and glassy carbon electrode (GCE). Best performance was observed on antimony film glassy carbon electrode (SbFGCE). It provided higher sensitivity and lower limit of quantification in comparison with bare GCE. The antimony film was stable and it provided good reproducibility (RSD = 5.2 %). Parameters of an electrochemical preparation of SbFGCE were optimized. Conditions for determination of concentration of trifluralin were optimized on newly prepared SbFGCE. The best conditions were in a solution of methanol and 0.1 M hydrochloric acid in 1:1 ratio measured by differential pulse voltammetry. The limit of quantification was determined as 1.2·10-6 mol·l-1 . A direct voltammetric measurement on SbFGCE was carried out in a model river sample. Lower limits of quantification were achieved with solid phase extraction (SPE). Recovery values were 86 ± 8 % in deionized water with a preconcentration factor of 125. The limit of quantification was lowered to value 1.1·10-8 mol·l-1 . The extraction...
22

Voltametrické stanovení diazepamu a nordiazepamu na meniskem modifikované stříbrné pevné amalgámové elektrodě / Voltammetric determination of diazepam and nordiazepam on meniscus modified silver solid amalgam electrode

Samiec, Petr January 2012 (has links)
Voltammetric methods for the determination of diazepam (DZ) and nordiazepam (NDZ) were developed. Techniques differential pulse voltammetry (DPV) and DC voltammetry for determination of both substances at meniscus modified silver solid amalgam electrode (m-AgSAE) were used. Effect of pHa in media of mixture of Britton-Robinson buffer and methanol (9:1) and 0,1 mol.l-1 NaOH was studied. Stability of the signal with repeated measurements in 0,1 mol.l-1 and methanol (9:1) was monitored. Optimal pHa 13,2 of 0,1 mol.l-1 NaOH was used for determination of DZ by DPV and DCV techniques. Optimal pHa 10,2 in media of mixture of Britton-Robinson buffer and methanol (9:1) was used for determination of NDZ by DPV and DCV techniques. Under these conditions were measured linear dependences in the calibration. Concentration range of DZ was measured with DCV in range of 1.10-4 - 6.10-6 mol.l-1 and DPV with DCV technique in range of 1.10-4 - 2.10-6 mol.l-1. Concentration range of NDZ was measured with DCV technique in range of 1.10-4 - 4.10-6 mol.l-1 and DPV technique in range of 1.10-4 - 2.10-6 mol.l-1. The limit of detection was calculated for DZ 6,6 .10-6 mol.l-1 with DCV and 1.10-6 mol.l-1 with DPV. The limit of detection was calculated for NDZ 5,5.10-6 mol.l-1 with DCV and 1,7.10-6 mol.l-1 with DPV. Developed method...
23

Voltametrické stanovení diazepamu a nordiazepamu na meniskem modifikované stříbrné pevné amalgámové elektrodě / Voltammetric determination of diazepam and nordiazepam on meniscus modified silver solid amalgam electrode

Samiec, Petr January 2013 (has links)
Voltammetric methods for the determination of diazepam (DZ) and nordiazepam (NDZ) were developed. Techniques differential pulse voltammetry (DPV) and DC voltammetry were used for determination of DZ and NDZ at meniscus modified silver solid amalgam electrode (m-AgSAE). The effect of pHa on the intensity of signal was observed in the mixture of Britton-Robinson buffer and methanol (9:1), and in the mixture of 0.1 mol.l−1 NaOH and methanol (9:1). The stability of the signal during repeated measurements in the mixture of 0.1 mol.l−1 NaOH and methanol (9:1), and in the mixture of BR buffer and methanol (9:1) was monitored. Optimal pHa 13.2 of medium of 0.1 mol.l−1 NaOH and methanol (9:1) was used for determination of DZ with DPV and DCV techniques. Optimal pHa 10.1 of medium of BR buffer and methanol (9:1) was used for determination of NDZ with DPV and DCV techniques. Under these conditions linear dependencies calibration were measured. Concentration range of DZ was measured with DCV in range of 10x10−5 - 6x10−6 mol.l−1 and with DPV technique in range of 10x10−5 - 2x10−6 mol.l−1 . Concentration range of NDZ was measured with DCV technique in range of 10x10−5 - 4x10−6 mol.l−1 and with DPV technique in range of 10x10−5 - 2x10−6 mol.l−1 . The limit of detection for DZ was calculated 6.6x10−6 mol.l−1 with DCV and...
24

Aplicação de eletrodos compósitos à base de grafite-poliuretana modificados com polímeros com impressão molecular, na determinação de ácido fólico e diclofenaco / Application of graphite-polyurethane composite electrodes modified with molecularly imprinted polymers in the determination of folic acid and diclofenac

Pereira, Abigail Vasconcelos 14 August 2015 (has links)
Neste trabalho foram preparados eletrodos compósitos grafite-poliuretana modificados com polímeros metacrilatos com impressão molecular (EGPU-MIP) visando a determinação de ácido fólico (FA) e forma ácida do diclofenaco (DCF), os quais foram usados como moléculas molde. O objetivo principal era avaliar o desempenho dos MIPs em relação à seletividade e sensibilidade, além da inovação em relação ao uso dos compósitos como material de eletrodo, relativamente a esses analitos. No caso do FA, os MIP foram preparados com essa molécula, relativamente grande e contendo vários grupos funcionais, para avaliar o efeito dessas características no desempenho do sensor. Inicialmente foram feitos estudos exploratórios usando voltametria cíclica (CV), nos quais o FA apresentou pico irreversível de oxidação em +0,80 V (vs. SCE) e picos reversíveis de redução em -0,40 e -0,65 V (vs. SCE), com respectivos processos de oxidação em -0,33 e -0,49 V (vs. SCE). Foi desenvolvido um procedimento analítico para determinação do fármaco usando voltametria de pulso diferencial (DPV), após otimizar parâmetros tais como composição de MIP no sensor de (2,5%, m/m), amplitude de pulso (a = 50 mV), velocidade de varredura (ν = 10 mV s-1) e meio eletrolítico (tampão acetato, pH = 4,5). Nesse procedimento, determinou-se uma mesma região linear de resposta entre 0,6 e 2,0 µmol L-1 para os dois picos de redução em -0,52 e -0,58 V (vs. SCE), com limites de detecção (LOD) de 0,17 e de 0,03 &micromol L-1, respectivamente. O pico em -0,58 V mostrou-se mais sensível e foi escolhido para determinar o FA nas formulações farmacêuticas Folacin&reg, Afopic&reg e Folifolim&reg, com resultados concordantes com o método oficial baseado na Cromatografia líquida de alta eficiência (HPLC), em 95% de confiança, segundo o teste t-Student. O MIP-FA mostrou-se mais seletivo que o polímero sem impressão molecular (NIP-DCF) frente às interferências do metotrexato (MTX), porem o ácido ascórbico (AA), ácido úrico (UA) e dopamina (DA) mostraram interferências, em relação aos grupos funcionais presentes nessas espécies, com forte influência da rigidez estrutural e da mobilidade rotacional de tais grupos. Outro MIP foi sintetizado com impressão para DCF. A voltametria cíclica mostrou que o DCF apresenta pico irreversível de oxidação em + 0,83 V (vs. SCE), na primeira varredura e picos reversíveis de redução em +0,40 e +0,65 V (vs. SCE), a partir da segunda varredura, com respectivos processos de oxidação em +0,27 e +0,58 V (vs. SCE). Foi desenvolvido um procedimento analítico para determinação do fármaco em formulações comerciais, usando DPAdASV, após otimização dos parâmetros tais como composição de MIP no sensor (2,5%, m/m), tempo de acumulação (300 s) e potencial de pré-concentração (+0,2 V), a = 50 mV, ν = 10 mV s-1 em ácido perclórico pH condicional (pHcond) = 1,6, com uma região linear entre 0,010 e 0,20 nmol L-1 e LOD de 0,99 nmol L-1 para o pico anódico em +0,8 V (vs. SCE). O DCF foi determinado nas formulações farmacêuticas Biofenac&reg, Medley&reg e Voltaren&reg e em urina sintética. O MIP-DCF se mostrou relativamente seletivo ao sinal do DCF, mesmo na presença dos interferentes como ácido meclofenâmico (AMCFN) e ácido mefenâmico (AMFN), os quais apresentam grande semelhança estrutural e funcional em relação ao analito. Deve-se tomar cuidado ao estender o intervalo de potencial operacional para o GPU, neste meio de ácido perclórico, para evitar ativação de grupos funcionais do grafite e/ou da PU. / In this work methacrylate molecularly imprinted polymers (MIP) were prepared using folic acid (FA) as well as diclofenac (DCF) templates. These MIPs were used in the modification of graphite-polyurethane (GPU) composites in order to evaluate the performance of the resulting electrodes in the determination of the templates in pharmaceutical formulations and to estimate the sensitivity and selectivity of the resulting devices joined to the innovation of using the composites in such development regarding these analytes. In the case of FA, MIPs were prepared with this relatively large and containing multiple functional groups, to evaluate the effect of such characteristics in the performance of the sensor. First of all exploratory experiments were performed using cyclic votammetry (CV) in which the FA presented an irreversible oxidation peak at + 0.80 V (vs. SCE) and reversible reductions peaks at -0.40 and -0.65 V (vs. SCE) with respective oxidation at -0.33 and -0.49 V (vs. SCE). An analytical procedure was developed based on differential pulse voltammetry (DPV), after optimizing parameters such as MIP composition in the sensor (2.5%, m/m), pulse amplitude (a = 50 mV), scan rate (ν = 10 mV s-1) and supporting electrolyte (acetate, pH = 4.5). In such procedure was obtained a linear dynamic range from 0.6 to 2.0 &micromol L-1 for both DPV reduction peaks at -0.52 and -0.58 V (vs. SCE), with limit of detection (LOD) of 0.17 and 0.03 &micromol L-1, respectively. As the second on was more sensitive it was chosen for the determination of FA in the commercial pharmaceutical formulation Folacin&reg, Afopic&reg and Folifolim&reg,with results that agreed with those from the official HPLC procedure within 95% confidence level according to the t-Student test. The MIP-FA was more selective than the non-imprinted polymer (NIP-DCF) in relation to the interference of metotrexate (MTX), however ascorbic acid (AA), uric acid (UA) and dopamine (DA) revealed significant interferences regarding the functional groups present in these species, with strong influence from the structural rigidity of the molecule that plays an important role in the rotational mobility of these groups. Another MIP was synthesized with DCF as a template. Cyclic voltammetry demonstrated that the DCF presented a single irreversible oxidation peak at + 0.83 V (vs. SCE) in the first scan, and two reversible reduction peaks at +0.40 and +0.65 V (vs. SCE) with respective oxidation at +0.27 and +0.58 V (vs. SCE), from the second scan. A DPAdASV procedure was also developed for the determination of DCF in commercial formulations after optimizing some experimental parameters such as MIP composition in the sensor (2.5%, m/m), accumulation time (300 s) and potential (+0.2 V), a = 50 mV, v = 10 mV s-1 and supporting electrolyte (perchloric acid pHcond = 1.6). A linear dynamic range from 0.010 to 0.20 nmol L-1 and a LOD of 0.99 nmol L-1 were observed for the anodic peak at +0.8 V (vs. SCE). Then the DCF was determined in the commercial formulations Biofenac&reg, Medley&reg and Voltaren&reg and also in synthetic urine samples. The MIP-DCF sensor showed to be selective regarding the DCF signal even in the presence of meclophenamic acid (AMCFN) and mefenamic acid (AMFN), which present structural and functional similarity when compared with the analyte. Care must be taken when using the GPU in extreme potential windows in the perchloric acid medium, to avoid activation of functional groups in the polymer.
25

Aplicação de eletrodos compósitos à base de grafite-poliuretana modificados com polímeros com impressão molecular, na determinação de ácido fólico e diclofenaco / Application of graphite-polyurethane composite electrodes modified with molecularly imprinted polymers in the determination of folic acid and diclofenac

Abigail Vasconcelos Pereira 14 August 2015 (has links)
Neste trabalho foram preparados eletrodos compósitos grafite-poliuretana modificados com polímeros metacrilatos com impressão molecular (EGPU-MIP) visando a determinação de ácido fólico (FA) e forma ácida do diclofenaco (DCF), os quais foram usados como moléculas molde. O objetivo principal era avaliar o desempenho dos MIPs em relação à seletividade e sensibilidade, além da inovação em relação ao uso dos compósitos como material de eletrodo, relativamente a esses analitos. No caso do FA, os MIP foram preparados com essa molécula, relativamente grande e contendo vários grupos funcionais, para avaliar o efeito dessas características no desempenho do sensor. Inicialmente foram feitos estudos exploratórios usando voltametria cíclica (CV), nos quais o FA apresentou pico irreversível de oxidação em +0,80 V (vs. SCE) e picos reversíveis de redução em -0,40 e -0,65 V (vs. SCE), com respectivos processos de oxidação em -0,33 e -0,49 V (vs. SCE). Foi desenvolvido um procedimento analítico para determinação do fármaco usando voltametria de pulso diferencial (DPV), após otimizar parâmetros tais como composição de MIP no sensor de (2,5%, m/m), amplitude de pulso (a = 50 mV), velocidade de varredura (ν = 10 mV s-1) e meio eletrolítico (tampão acetato, pH = 4,5). Nesse procedimento, determinou-se uma mesma região linear de resposta entre 0,6 e 2,0 µmol L-1 para os dois picos de redução em -0,52 e -0,58 V (vs. SCE), com limites de detecção (LOD) de 0,17 e de 0,03 &micromol L-1, respectivamente. O pico em -0,58 V mostrou-se mais sensível e foi escolhido para determinar o FA nas formulações farmacêuticas Folacin&reg, Afopic&reg e Folifolim&reg, com resultados concordantes com o método oficial baseado na Cromatografia líquida de alta eficiência (HPLC), em 95% de confiança, segundo o teste t-Student. O MIP-FA mostrou-se mais seletivo que o polímero sem impressão molecular (NIP-DCF) frente às interferências do metotrexato (MTX), porem o ácido ascórbico (AA), ácido úrico (UA) e dopamina (DA) mostraram interferências, em relação aos grupos funcionais presentes nessas espécies, com forte influência da rigidez estrutural e da mobilidade rotacional de tais grupos. Outro MIP foi sintetizado com impressão para DCF. A voltametria cíclica mostrou que o DCF apresenta pico irreversível de oxidação em + 0,83 V (vs. SCE), na primeira varredura e picos reversíveis de redução em +0,40 e +0,65 V (vs. SCE), a partir da segunda varredura, com respectivos processos de oxidação em +0,27 e +0,58 V (vs. SCE). Foi desenvolvido um procedimento analítico para determinação do fármaco em formulações comerciais, usando DPAdASV, após otimização dos parâmetros tais como composição de MIP no sensor (2,5%, m/m), tempo de acumulação (300 s) e potencial de pré-concentração (+0,2 V), a = 50 mV, ν = 10 mV s-1 em ácido perclórico pH condicional (pHcond) = 1,6, com uma região linear entre 0,010 e 0,20 nmol L-1 e LOD de 0,99 nmol L-1 para o pico anódico em +0,8 V (vs. SCE). O DCF foi determinado nas formulações farmacêuticas Biofenac&reg, Medley&reg e Voltaren&reg e em urina sintética. O MIP-DCF se mostrou relativamente seletivo ao sinal do DCF, mesmo na presença dos interferentes como ácido meclofenâmico (AMCFN) e ácido mefenâmico (AMFN), os quais apresentam grande semelhança estrutural e funcional em relação ao analito. Deve-se tomar cuidado ao estender o intervalo de potencial operacional para o GPU, neste meio de ácido perclórico, para evitar ativação de grupos funcionais do grafite e/ou da PU. / In this work methacrylate molecularly imprinted polymers (MIP) were prepared using folic acid (FA) as well as diclofenac (DCF) templates. These MIPs were used in the modification of graphite-polyurethane (GPU) composites in order to evaluate the performance of the resulting electrodes in the determination of the templates in pharmaceutical formulations and to estimate the sensitivity and selectivity of the resulting devices joined to the innovation of using the composites in such development regarding these analytes. In the case of FA, MIPs were prepared with this relatively large and containing multiple functional groups, to evaluate the effect of such characteristics in the performance of the sensor. First of all exploratory experiments were performed using cyclic votammetry (CV) in which the FA presented an irreversible oxidation peak at + 0.80 V (vs. SCE) and reversible reductions peaks at -0.40 and -0.65 V (vs. SCE) with respective oxidation at -0.33 and -0.49 V (vs. SCE). An analytical procedure was developed based on differential pulse voltammetry (DPV), after optimizing parameters such as MIP composition in the sensor (2.5%, m/m), pulse amplitude (a = 50 mV), scan rate (ν = 10 mV s-1) and supporting electrolyte (acetate, pH = 4.5). In such procedure was obtained a linear dynamic range from 0.6 to 2.0 &micromol L-1 for both DPV reduction peaks at -0.52 and -0.58 V (vs. SCE), with limit of detection (LOD) of 0.17 and 0.03 &micromol L-1, respectively. As the second on was more sensitive it was chosen for the determination of FA in the commercial pharmaceutical formulation Folacin&reg, Afopic&reg and Folifolim&reg,with results that agreed with those from the official HPLC procedure within 95% confidence level according to the t-Student test. The MIP-FA was more selective than the non-imprinted polymer (NIP-DCF) in relation to the interference of metotrexate (MTX), however ascorbic acid (AA), uric acid (UA) and dopamine (DA) revealed significant interferences regarding the functional groups present in these species, with strong influence from the structural rigidity of the molecule that plays an important role in the rotational mobility of these groups. Another MIP was synthesized with DCF as a template. Cyclic voltammetry demonstrated that the DCF presented a single irreversible oxidation peak at + 0.83 V (vs. SCE) in the first scan, and two reversible reduction peaks at +0.40 and +0.65 V (vs. SCE) with respective oxidation at +0.27 and +0.58 V (vs. SCE), from the second scan. A DPAdASV procedure was also developed for the determination of DCF in commercial formulations after optimizing some experimental parameters such as MIP composition in the sensor (2.5%, m/m), accumulation time (300 s) and potential (+0.2 V), a = 50 mV, v = 10 mV s-1 and supporting electrolyte (perchloric acid pHcond = 1.6). A linear dynamic range from 0.010 to 0.20 nmol L-1 and a LOD of 0.99 nmol L-1 were observed for the anodic peak at +0.8 V (vs. SCE). Then the DCF was determined in the commercial formulations Biofenac&reg, Medley&reg and Voltaren&reg and also in synthetic urine samples. The MIP-DCF sensor showed to be selective regarding the DCF signal even in the presence of meclophenamic acid (AMCFN) and mefenamic acid (AMFN), which present structural and functional similarity when compared with the analyte. Care must be taken when using the GPU in extreme potential windows in the perchloric acid medium, to avoid activation of functional groups in the polymer.
26

Molecularly imprinted polymer sensor systems for environmental estrogenic endocrine disrupting chemicals

Ntshongontshi, Nomaphelo January 2018 (has links)
Philosophiae Doctor - PhD (Chemistry) / There is growing concern on endocrine disrupting compounds (EDCs). The presence of drugs in water supplies was first realized in Germany in the early 1990s when environmental scientists discovered clofibric acid. Clofibric acid has the ability to lower cholesterol in ground water below a water treatment plant. Endocrine disrupting compounds can be defined as those chemicals with the ability to alter daily functioning of the endocrine system in living organisms. There are numerous molecules that are regarded or referred to as EDCs such as but not limited to organochlorinated pesticides, industrial chemicals, plastics and plasticizers, fuels, estrogens and many other chemicals that are found in the environment or are in widespread use. 17?- estradiol is the principal estrogen found in mammals during reproductive years. Estriol is produced in large quantities during pregnancy. 17?-estradiol is the strongest, estriol the weakest. Estriol is water soluble, estrone and estradiol are not. Although estrogen is produced in women they are also at risk of over exposure to estrogen. Pesticides are extensively used today in agricultural settings to prevent and control pests. Various pesticides, including banned organochlorines (OCs) and modern non-persistent pesticides, have shown the ability to disrupt thyroid activity, disturbing the homeostasis of the thyroid system. Because these EDCs have adverse effects on health of both human and wildlife, it is imperative to develop viable costeffective analytical methods for the detection of these EDCs in complicated samples and at very low concentrations. Very high selectivity towards particular compounds is a very important property for the suitability of a detection method. This is because these compounds mostly coexist in complex matrices which makes the detection of a specific compound very challenging. It is paramount to develop highly sensitive and selective methods for the detection of these estrogens and phosphoric acid-based pesticides at trace levels. / 2021-08-31
27

Polymeric tyrosinase nanobiosensor system for the determination of endocrine disrupting bisphenol A

Matyholo, Virginia Busiswa January 2011 (has links)
The main objective of this work was to develop simple and sensitive electrochemical sensors for the detection of bisphenol A. To investigate the electrochemical behavior of BPA on a bare glassy carbon electrode. To apply the developed biosensor for the determination BPA by differential pulse voltammetry, electrochemical impedance spectrometry, square wave voltammetry and steady-state amperometry. To characterize the synthesized PDMA-PSS by cyclic voltammetry (CV), UV-Vis spectroscopy, transmission electron microscopy (TEM), scanning electron microscopy (SEM).
28

Polymeric tyrosinase nanobiosensor system for the determination of endocrine disrupting bisphenol A

Matyholo, Virginia Busiswa January 2011 (has links)
The main objective of this work was to develop simple and sensitive electrochemical sensors for the detection of bisphenol A. To investigate the electrochemical behavior of BPA on a bare glassy carbon electrode. To apply the developed biosensor for the determination BPA by differential pulse voltammetry, electrochemical impedance spectrometry, square wave voltammetry and steady-state amperometry. To characterize the synthesized PDMA-PSS by cyclic voltammetry (CV), UV-Vis spectroscopy, transmission electron microscopy (TEM), scanning electron microscopy (SEM).
29

Polymeric tyrosinase nanobiosensor system for the determination of endocrine disrupting bisphenol A

Matyholo, Virginia Busiswa January 2011 (has links)
Magister Scientiae - MSc / The main objective of this work was to develop simple and sensitive electrochemical sensors for the detection of bisphenol A. To investigate the electrochemical behavior of BPA on a bare glassy carbon electrode. To apply the developed biosensor for the determination BPA by differential pulse voltammetry, electrochemical impedance spectrometry, square wave voltammetry and steady-state amperometry. To characterize the synthesized PDMA-PSS by cyclic voltammetry (CV), UV-Vis spectroscopy, transmission electron microscopy (TEM), scanning electron microscopy (SEM). / South Africa
30

Determina??o voltam?trica de estriol em formula??o farmac?utica e urina utilizando um eletrodo de carbono v?treo modificado com um filme de poli(metionina) e cobalto

Gomes, Eliziana Santana 28 July 2017 (has links)
Submitted by Jos? Henrique Henrique (jose.neves@ufvjm.edu.br) on 2018-06-26T00:47:56Z No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) eliziana_santana_gomes.pdf: 3970415 bytes, checksum: 2481c11516ababe53f6e97ce77e43efc (MD5) / Approved for entry into archive by Rodrigo Martins Cruz (rodrigo.cruz@ufvjm.edu.br) on 2018-07-18T12:49:10Z (GMT) No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) eliziana_santana_gomes.pdf: 3970415 bytes, checksum: 2481c11516ababe53f6e97ce77e43efc (MD5) / Made available in DSpace on 2018-07-18T12:49:10Z (GMT). No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) eliziana_santana_gomes.pdf: 3970415 bytes, checksum: 2481c11516ababe53f6e97ce77e43efc (MD5) Previous issue date: 2017 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES) / O estriol (C18H24O3, denominado E3) ? o principal esteroide estrog?nico produzido na gravidez. O uso do estriol ? comum para o tratamento da menopausa como alternativa ao 17?- estradiol, estrona ou a uma combina??o destes dois f?rmacos. O principal objetivo deste trabalho foi estudar o perfil voltam?trico do estriol utilizando a voltametria c?clica e desenvolver uma metodologia para a sua determina??o em comprimidos e urina utilizando a voltametria de pulso diferencial (DPV) e o eletrodo de carbono v?treo modificado com um filme de polimetionina e cobalto. Os resultados mostraram que em solu??o de tamp?o fosfato a 0,1 mol L-1 (pH 7,0) o E3 oxidou irreversivelmente no potencial de +0,58V, apresentando uma boa defini??o do pico. A curva anal?tica para o E3 foi linear no intervalo de concentra??o de 0,60 ?mol L-1 ? 4,76 ?mol L-1 (R2 = 0,996) e 5,66 ?mol L-1 ? 9,90 ?mol L-1 (R2 = 0,994), com limites de detec??o e de quantifica??o iguais a 3,40x10-8 mol L-1 e 1,13 x 10-7 mol L-1, respectivamente. A precis?o foi avaliada atrav?s de an?lises voltam?tricas do estriol realizadas em um mesmo dia e em dias diferentes e apresentaram desvios padr?es relativos (RSD) inferiores a 5,0%, mostrando que o m?todo desenvolvido ? preciso. Os estudos sobre interferentes mostraram que as subst?ncias presentes nas amostras de comprimido (lactose, estearato de magn?sio e amido) ou urina (?cido ?rico, ?cido asc?rbico e ?cido c?trico) n?o interferiram de maneira significativa na determina??o do E3. Al?m disso, o m?todo desenvolvido foi comparado estatisticamente com um m?todo citado na farmacop?ia atrav?s do teste-t e do teste-F. Os resultados mostraram que os valores de t e F calculados foram menores do que os valores de t e F cr?ticos, indicando que n?o houve diferen?a estat?stica significativa entre os m?todos. A exatid?o do m?todo foi avaliada tamb?m por estudos de adi??o e recupera??o. As recupera??es do E3 variaram de 97,7 ? 100,9% para a formula??o farmac?utica e 99,0 ? 100,9% para a urina, indicando que n?o houve efeitos de interfer?ncia de matriz significativos e que o m?todo apresenta boa exatid?o. Desta forma, a valida??o da metodologia desenvolvida demonstrou que o m?todo proposto pode ser aplicado com sucesso na determina??o do E3 em medicamentos e urina humana. / Disserta??o (Mestrado) ? Programa de P?s-gradua??o em Ci?ncias Farmac?uticas, Universidade Federal dos Vales do Jequitinhonha e Mucuri, 2017. / The estriol (C18H24O3, named as E3) is the main estrogenic steroid produced during pregnancy. The E3 is used to treatment of menopause as an alternative for 17?-estradiol, estrone or a combination of both. The main goal of this work was to study the voltammetric profile of E3 using cyclic voltammetry in order to develop a methodology for its determination in tablets and urine using differential pulse voltammetry (DPV) and the glass carbon electrode modified with a film of polymethionine and cobalt. The results showed that the E3 was oxidized at + 0.58V in a 0.1 molL-1 phosphate buffer solution (pH 7.0), giving a good peak definition. The analytical curve for E3 was linear in the concentration range of 0.60 ?molL-1 ? 4.76 ?molL-1 (R2 = 0.996) and 5.66 ?molL-1 ? 9.90 ?molL- 1 (R2 = 0.994 with lmits of detection and quantification of 3.40x10-8 molL-1 and 1.13x10-7 molL-1, respectively. The precision was evaluated by recording voltammograms of E3 on the same or different day. The relative standard deviations were lower than 5.0% for each test, indicating that the developed method has good precision. The interfering study showed that the tested substances do not interfered significantly in the determination of E3, as for both tablets (lactose, magnesium stearate and starch) or urine test (uric acid, ascorbic acid and citric acid). Furthermore, the developed method was compared to the suggested method from American Pharmacopoeia using the t-test and the F-test. The results showed that the calculated values of t and F were lower than their critical values, indicating no significant statistical difference between the methods. The accuracy of the method was also evaluated by studies of addition and recovery. The recovery of E3 ranged from 97.7 ? 100.9% for the pharmaceutical formulation and 99.0 ? 100.9% for the urine, indicating no significant effects of matrix interference and that the developed method presented accuracy. Thus, the validation of the developed methodology demonstrated that the proposed method can be applied successfully to the determination of E3 in drugs and human urine.

Page generated in 0.0857 seconds